Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-24-000811

Chief Financial Officer acquired 590,413 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Alam Kamran · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-02 Grant or award : show line 1 in the form +590,413 842,225 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-02 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +590,413 590,413 D
Loading xslF345X05/doc4.xml…